Chapter 1. Preface

1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology

Chapter 2. Executive Summary

2.1 Global Medicare Advantage Market Market, (2025 - 2034) (USD Billion)
2.2 Global Medicare Advantage Market Market: Snapshot

Chapter 3. Global Medicare Advantage Market Market - Industry Analysis

3.1 Medicare Advantage Market Market: Market Dynamics
3.2 Market Drivers
3.2.1 The Medicare Advantage Market is driven by the 2026 aging-into-Medicare surge of the baby boomer generation, a record 42% year-over-year growth in Chronic Condition Special Needs Plans (C-SNPs), the maturation of value-based care models supported by AI-driven predictive risk assessment, and the continued appeal of "all-in-one" supplemental benefits like dental, vision, and telehealth despite tightening federal reimbursement margins.
3.3 Market Restraints
3.3.1 The Medicare Advantage Market is restrained by the final 100% implementation of the V28 risk adjustment model in 2026—which has removed over 2,000 diagnosis codes—persistent margin compression from declining Star Rating quality bonuses, a 10% reduction in total plan offerings as national carriers exit unprofitable counties, and medical cost trends reaching a 10-year high of 9% due to increased utilization of GLP-1 drugs and specialty therapies.
3.4 Market Opportunities
3.4.1 The Medicare Advantage Market is driven by the 2026 "SNP Supercycle," featuring a 42% surge in Chronic Condition plans (C-SNPs), the expansion of AI-driven Social Determinants of Health (SDOH) integration to improve risk adjustment, and a strategic pivot toward value-based care partnerships that stabilize margins despite tightening federal reimbursements.
3.5 Market Challenges
3.5.1 The Medicare Advantage Market is challenged by the 2026 completion of the V28 risk-adjustment phase-in which has cut revenue for many plans, a 9% decrease in total plan offerings as national carriers exit unprofitable counties, the administrative burden of new FHIR-based prior authorization interoperability mandates, and medical loss ratios pressured by a 10-year high in healthcare utilization costs.
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Plan Type
3.7.2 Market attractiveness analysis By Application
3.7.3 Market attractiveness analysis By End-User

Chapter 4. Global Medicare Advantage Market Market- Competitive Landscape

4.1 Company market share analysis
4.1.1 Global Medicare Advantage Market Market: company market share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis

Chapter 5. Global Medicare Advantage Market Market - Plan Type Analysis

5.1 Global Medicare Advantage Market Market Overview: Plan Type
5.1.1 Global Medicare Advantage Market Market share, By Plan Type, 2024 and 2034
5.2 HMO
5.2.1 Global Medicare Advantage Market Market by HMO, 2025 - 2034 (USD Billion)
5.3 PPO
5.3.1 Global Medicare Advantage Market Market by PPO, 2025 - 2034 (USD Billion)
5.4 SNP
5.4.1 Global Medicare Advantage Market Market by SNP, 2025 - 2034 (USD Billion)
5.5 PFFS
5.5.1 Global Medicare Advantage Market Market by PFFS, 2025 - 2034 (USD Billion)
5.6 MSA
5.6.1 Global Medicare Advantage Market Market by MSA, 2025 - 2034 (USD Billion)
5.7 HMOPOS
5.7.1 Global Medicare Advantage Market Market by HMOPOS, 2025 - 2034 (USD Billion)
5.8 and Others
5.8.1 Global Medicare Advantage Market Market by and Others, 2025 - 2034 (USD Billion)

Chapter 6. Global Medicare Advantage Market Market - Application Analysis

6.1 Global Medicare Advantage Market Market Overview: Application
6.1.1 Global Medicare Advantage Market Market share, By Application, 2024 and 2034
6.2 Individual
6.2.1 Global Medicare Advantage Market Market by Individual, 2025 - 2034 (USD Billion)
6.3 Group
6.3.1 Global Medicare Advantage Market Market by Group, 2025 - 2034 (USD Billion)
6.4 and Others
6.4.1 Global Medicare Advantage Market Market by and Others, 2025 - 2034 (USD Billion)

Chapter 7. Global Medicare Advantage Market Market - End-User Analysis

7.1 Global Medicare Advantage Market Market Overview: End-User
7.1.1 Global Medicare Advantage Market Market share, By End-User, 2024 and 2034
7.2 Senior Citizens
7.2.1 Global Medicare Advantage Market Market by Senior Citizens, 2025 - 2034 (USD Billion)
7.3 Disabled Beneficiaries
7.3.1 Global Medicare Advantage Market Market by Disabled Beneficiaries, 2025 - 2034 (USD Billion)
7.4 and Others
7.4.1 Global Medicare Advantage Market Market by and Others, 2025 - 2034 (USD Billion)

Chapter 8. Medicare Advantage Market Market - Regional Analysis

8.1 Global Medicare Advantage Market Market Regional Overview
8.2 Global Medicare Advantage Market Market Share, by Region, 2024 & 2034 (USD Billion)
8.3 North America
8.3.1 North America Medicare Advantage Market Market, 2025 - 2034 (USD Billion)
8.3.1.1 North America Medicare Advantage Market Market, by Country, 2025 - 2034 (USD Billion)
8.3.2 North America Medicare Advantage Market Market, by Plan Type, 2025 - 2034
8.3.2.1 North America Medicare Advantage Market Market, by Plan Type, 2025 - 2034 (USD Billion)
8.3.3 North America Medicare Advantage Market Market, by Application, 2025 - 2034
8.3.3.1 North America Medicare Advantage Market Market, by Application, 2025 - 2034 (USD Billion)
8.3.4 North America Medicare Advantage Market Market, by End-User, 2025 - 2034
8.3.4.1 North America Medicare Advantage Market Market, by End-User, 2025 - 2034 (USD Billion)
8.4 Europe
8.4.1 Europe Medicare Advantage Market Market, 2025 - 2034 (USD Billion)
8.4.1.1 Europe Medicare Advantage Market Market, by Country, 2025 - 2034 (USD Billion)
8.4.2 Europe Medicare Advantage Market Market, by Plan Type, 2025 - 2034
8.4.2.1 Europe Medicare Advantage Market Market, by Plan Type, 2025 - 2034 (USD Billion)
8.4.3 Europe Medicare Advantage Market Market, by Application, 2025 - 2034
8.4.3.1 Europe Medicare Advantage Market Market, by Application, 2025 - 2034 (USD Billion)
8.4.4 Europe Medicare Advantage Market Market, by End-User, 2025 - 2034
8.4.4.1 Europe Medicare Advantage Market Market, by End-User, 2025 - 2034 (USD Billion)
8.5 Asia Pacific
8.5.1 Asia Pacific Medicare Advantage Market Market, 2025 - 2034 (USD Billion)
8.5.1.1 Asia Pacific Medicare Advantage Market Market, by Country, 2025 - 2034 (USD Billion)
8.5.2 Asia Pacific Medicare Advantage Market Market, by Plan Type, 2025 - 2034
8.5.2.1 Asia Pacific Medicare Advantage Market Market, by Plan Type, 2025 - 2034 (USD Billion)
8.5.3 Asia Pacific Medicare Advantage Market Market, by Application, 2025 - 2034
8.5.3.1 Asia Pacific Medicare Advantage Market Market, by Application, 2025 - 2034 (USD Billion)
8.5.4 Asia Pacific Medicare Advantage Market Market, by End-User, 2025 - 2034
8.5.4.1 Asia Pacific Medicare Advantage Market Market, by End-User, 2025 - 2034 (USD Billion)
8.6 Latin America
8.6.1 Latin America Medicare Advantage Market Market, 2025 - 2034 (USD Billion)
8.6.1.1 Latin America Medicare Advantage Market Market, by Country, 2025 - 2034 (USD Billion)
8.6.2 Latin America Medicare Advantage Market Market, by Plan Type, 2025 - 2034
8.6.2.1 Latin America Medicare Advantage Market Market, by Plan Type, 2025 - 2034 (USD Billion)
8.6.3 Latin America Medicare Advantage Market Market, by Application, 2025 - 2034
8.6.3.1 Latin America Medicare Advantage Market Market, by Application, 2025 - 2034 (USD Billion)
8.6.4 Latin America Medicare Advantage Market Market, by End-User, 2025 - 2034
8.6.4.1 Latin America Medicare Advantage Market Market, by End-User, 2025 - 2034 (USD Billion)
8.7 The Middle-East and Africa
8.7.1 The Middle-East and Africa Medicare Advantage Market Market, 2025 - 2034 (USD Billion)
8.7.1.1 The Middle-East and Africa Medicare Advantage Market Market, by Country, 2025 - 2034 (USD Billion)
8.7.2 The Middle-East and Africa Medicare Advantage Market Market, by Plan Type, 2025 - 2034
8.7.2.1 The Middle-East and Africa Medicare Advantage Market Market, by Plan Type, 2025 - 2034 (USD Billion)
8.7.3 The Middle-East and Africa Medicare Advantage Market Market, by Application, 2025 - 2034
8.7.3.1 The Middle-East and Africa Medicare Advantage Market Market, by Application, 2025 - 2034 (USD Billion)
8.7.4 The Middle-East and Africa Medicare Advantage Market Market, by End-User, 2025 - 2034
8.7.4.1 The Middle-East and Africa Medicare Advantage Market Market, by End-User, 2025 - 2034 (USD Billion)

Chapter 9. Company Profiles

9.1 UnitedHealth Group
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Humana Inc.
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 CVS Health Corporation (Aetna)
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Elevance Health
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Centene Corporation
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 and Others.
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments

Frequently Asked Questions

The Medicare Advantage market consists of private health plans approved by CMS that provide Medicare Parts A and B benefits, often with extras like drug coverage.

Factors include aging demographics, regulatory changes, supplemental benefit demands, and technological integrations for better care management.

The market is expected to expand from around USD 494 billion in 2026 to USD 1200 billion by 2035.

The CAGR is anticipated to be 9.3% from 2026 to 2035.

North America, specifically the U.S., will contribute notably as the primary market hub.

Major players are UnitedHealth Group, Humana Inc., CVS Health Corporation (Aetna), Elevance Health, and Centene Corporation.

The report includes market size, trends, segmentation, key players, regional analysis, and forecasts to 2035.

Stages encompass plan design, CMS approval, marketing, enrollment, care delivery, and claims processing.

Trends favor SNPs and digital tools, with preferences shifting to plans with wellness and SDOH benefits.

CMS payment adjustments, IRA drug changes, and star rating shifts influence growth and plan strategies.